A2 Biotherapeutics Revenue and Competitors
Estimated Revenue & Valuation
- A2 Biotherapeutics's estimated annual revenue is currently $32.4M per year.
- A2 Biotherapeutics's estimated revenue per employee is $193,750
- A2 Biotherapeutics's total funding is $128.5M.
Employee Data
- A2 Biotherapeutics has 167 Employees.
- A2 Biotherapeutics grew their employee count by 1% last year.
A2 Biotherapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | President and CEO | Reveal Email/Phone |
3 | Chief Business Officer | Reveal Email/Phone |
4 | VP, Head Technical Operations | Reveal Email/Phone |
5 | VP Discovery Research | Reveal Email/Phone |
6 | VP, Head Regulatory Affairs | Reveal Email/Phone |
7 | Scientific Director | Reveal Email/Phone |
8 | Director, Head Manufacturing Operations | Reveal Email/Phone |
9 | Chief Financial Officer | Reveal Email/Phone |
10 | Clinical Development Associate Director | Reveal Email/Phone |
A2 Biotherapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is A2 Biotherapeutics?
A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer. We are focused on the next frontier in cell therapy: solid tumors. Our approach addresses the central problem of cancer research: tumor-targeted killing. We focus on targets either lost or gained in cancer cells, potentially creating breakthrough therapies to treat most cancers. The company was founded in 2018 by Alexander Kamb, Michael Gallo and Paul Kang and raised a Series A financing of $57 million (The Column Group, Vida Ventures, Samsara Capital and Nextech Invest).
keywords:N/A
$128.5M
Total Funding
167
Number of Employees
$32.4M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
A2 Biotherapeutics News
Geneos Therapeutics, a Plymouth Meeting, PA- based clinical stage biotherapeutics company, raised $17M in Series A2 funding.
Geneos Therapeutics Secures $17 Million in Series A2 Financing to Advance Personalized Cancer Immunotherapy Platform · Geneos expands its Phase...
("A2 Bio''), a biotechnology company focused on the treatment of solid tumors, announced today that key preclinical data related to its...
Other Companies in Agoura Hills
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $46.3M | 167 | 4% | $8.2M |
#2 | $50.5M | 201 | 12% | N/A |
#3 | $66.8M | 225 | 3% | N/A |
#4 | $51.8M | 269 | 9% | N/A |
#5 | $78.4M | 307 | 4% | N/A |